Key facts
| Price (PPV) | 2,003 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | bictegraviremtricitabine tenofovir alafenamide |
| Class | Antivirals for systemic use |
| ATC code | J05AR20 |
| Manufacturer | AFRIC-PHAR |
| Presentation | Boite d'un flacon de 30 |
| Hospital price | 1,753 MAD |
| Data collected on | 9/8/2026 |
Indications
Biktarvy est indiqué pour le traitement de l’infection par le virus de l’immunodéficience humaine de type 1 (VIH-1) chez les patients adultes et pédiatriques âgés d’au moins 2 ans et pesant au moins 14 kg sans preuve actuelle ou antérieure de résistance à la classe des inhibiteurs de l’intégrase, à l’emtricitabine ou au ténofovir
Find an open pharmacy
On-call pharmacies near you
About Biktarvy 50 mg / 200 mg / 25 mg
Biktarvy 50 mg / 200 mg / 25 mg belongs to the antivirals for systemic use therapeutic class. In Morocco, this drug is marketed by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Biktarvy 50 mg / 200 mg / 25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Biktarvy 50 mg / 200 mg / 25 mg
Answers to common questions from Moroccan patients about this drug.